Charantin and polypeptide P are two bioactive compounds in bitter melon studied for blood sugar. Learn how they differ, what research says, and safety.
Charantin and polypeptide P are two different bioactive compounds found in bitter melon (Momordica charantia). Charantin is a mixture of steroidal saponins, while polypeptide P is a plant-derived protein with insulin-like properties. Both are studied for blood sugar support, but neither is FDA-approved to treat or prevent diabetes.
What Is Charantin?
Charantin is a group of steroidal saponins found mainly in bitter melon fruit, seeds, and leaves. It is often described as a single compound, but charantin is actually a mixture that includes related saponins such as diosgenin and sitosterol glucoside.
Laboratory and animal studies suggest charantin may help cells take up glucose. However, charantin is poorly absorbed from the gut, which limits how much reaches the bloodstream. Human research on isolated charantin is also very limited.
What Is Polypeptide P?
Polypeptide P — also called p-insulin or plant insulin — is a protein found in bitter melon. If you are wondering what is a polypeptide, it is simply a short chain of amino acids linked by peptide bonds. Polypeptide P fits that definition and has a polypeptide structure that resembles insulin enough to interest diabetes researchers.
Common polypeptide examples in medicine include insulin and glucagon. Polypeptide P is not the same as human insulin, and it is not sold as a prescription drug in the United States. Scientists have studied it for decades, but mostly in laboratory and animal models.
Charantin vs. Polypeptide P: Key Differences
| Feature | Charantin | Polypeptide P |
|---|---|---|
| Chemical class | Steroidal saponin mixture | Protein / polypeptide |
| Main source | Bitter melon fruit, seeds, leaves | Bitter melon fruit and seeds |
| Studied effect | Glucose uptake, insulin sensitivity | Insulin-like blood sugar lowering |
| Human evidence | Small, mixed trials using whole extract | Very limited; mostly lab and animal data |
| FDA approval | Not approved as a drug | Not approved as a drug |
| Common forms | Oral capsules, teas, powders | Oral extracts; not injectable |
How They Are Studied for Blood Sugar
Bitter melon has a long history of use in traditional medicine for diabetes. Modern researchers have tried to isolate which compounds are responsible. Charantin and polypeptide P are two leading candidates, but the evidence is not strong enough to recommend either one as a stand-alone treatment.
Mechanistic studies suggest charantin may increase glucose uptake in muscle and fat cells, while polypeptide P may interact with insulin receptors. These are early findings. Most human trials use whole bitter melon powder, juice, or extract, so researchers cannot tell whether charantin, polypeptide P, or another compound is responsible for any effect.
Several small human studies of bitter melon extract have shown modest reductions in fasting blood sugar. Others found no meaningful difference compared with placebo. The results are inconsistent, partly because extracts vary in charantin and polypeptide P content.
No large, high-quality human trial has proven that charantin or polypeptide P alone lowers blood sugar in people with diabetes.
Forms, Dosing, and Labeling
Bitter melon supplements are not standardized, so the amount of charantin or polypeptide P in a product can vary widely. Some labels state a charantin percentage, such as 0.5% or 1%, but polypeptide P is rarely listed. Typical study doses range from 500 mg to 2,000 mg of bitter melon extract per day, but there is no standard dose.
Unlike the medicines on a list of injectable peptides and what they do, polypeptide P is not an injectable prescription product. It is studied as a component of oral bitter melon extracts. Researchers may use a polypeptide calculator to estimate molecular weight in the lab, but that tool does not translate into a safe human dose.
Some skincare products also use the word polypeptide on their labels. Those topical peptides are used for skin hydration and have nothing to do with charantin or polypeptide P.
Safety, Side Effects, and Interactions
Bitter melon is generally considered safe in food amounts. Concentrated supplements may cause digestive upset, including nausea, diarrhea, and stomach cramps.
The bigger concern is low blood sugar. Bitter melon can add to the effects of insulin, sulfonylureas, and other diabetes medications. That combination can cause hypoglycemia, which can be dangerous. People with diabetes should check their blood sugar more often if they add bitter melon to their routine.
- Pregnancy: Bitter melon may stimulate the uterus and should be avoided in medicinal amounts during pregnancy.
- G6PD deficiency: Some bitter melon products have been linked to hemolytic anemia in people with this condition.
- Liver health: Rare reports of liver problems exist with bitter melon seed extracts.
- Surgery: Stop bitter melon supplements at least two weeks before surgery because of blood sugar effects.
Always talk with a healthcare professional before using bitter melon, charantin, or polypeptide P supplements, especially if you take diabetes medication.
The Bottom Line
Charantin and polypeptide P are two different compounds from the same plant. Charantin is a saponin mixture, and polypeptide P is an insulin-like protein. Both are interesting research targets, but neither has enough human evidence or regulatory approval to replace standard diabetes care.
If you want to try bitter melon, choose a reputable brand, tell your doctor, and monitor your blood sugar closely. Do not stop or change prescribed medication without medical guidance.
Frequently Asked Questions
Is polypeptide P the same as charantin?
No. Charantin is a mixture of steroidal saponins, while polypeptide P is a protein with insulin-like activity. They come from the same plant, but they are chemically different and are studied separately.
Can charantin and polypeptide P lower blood sugar in humans?
Laboratory and animal studies suggest both may have glucose-lowering effects. Human trials using whole bitter melon extract show mixed results, and no large study has proven that either compound works on its own. Neither is FDA-approved for diabetes.
Are bitter melon supplements safe to take with diabetes medication?
Bitter melon can add to the blood sugar-lowering effects of insulin and sulfonylureas, which raises the risk of hypoglycemia. Talk with your healthcare professional before combining them, and monitor your blood sugar closely. Bitter melon supplements are not standardized, so potency can vary.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.